VRDN EPS Estimates
Viridian Therapeutics, Inc.
$18.34
+$0.06(+0.33%)
46
Overall
60
Value
45
Tech
34
Quality
Market Cap
$2.07B
Volume
2.44M
52W Range
$13.18 - $34.29
Target Price
$36.88
VRDN EPS estimates: the consensus estimate for Viridian Therapeutics, Inc.'s current fiscal year is -$4.07 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
VRDN EPS Estimates
- EPS estimate, current quarter
- $-1.08
- EPS estimate, next quarter
- $-0.94
- EPS estimate, current year
- $-4.07
- EPS estimate, next year
- $-2.43
- EPS growth, 3-year
- +6.41%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.32 |
| 2024 | $-3.07 |
| 2023 | $-5.31 |
| 2022 | $-4.05 |
| 2021 | $-6.66 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRDN | $18.34 | +0.3% | 2.44M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Viridian Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW